What is Human Chorionic Gonadotropin (hCG)?

Human chorionic gonadotropin (hCG) is a hormone that trophoblast cells produce around a growing embryo. These cells later become the placenta after implantation. This hormone acts as the main pregnancy indicator and plays several vital roles in early pregnancy support.

hCG is a glycoprotein made up of 237 amino acids with a molecular mass of 36.7 kDa. The hormone has two distinct subunits: an alpha (α) subunit that’s similar to other hormones like luteinizing hormone, and a unique beta (β) subunit. The beta subunit contains 145 amino acids that six highly homologous genes encode on chromosome 19q13.3.

The hormone’s main job during pregnancy is to boost progesterone production by the corpus luteum until the placenta develops fully. This happens about 10 weeks into pregnancy when the placenta can make enough progesterone on its own. Progesterone helps maintain the uterine lining and supports embryo development.

The body starts producing hCG right after the fertilized egg attaches to the uterine wall. The levels increase faster in early pregnancy and typically double every 2-3 days for the first 8-10 weeks. These levels peak around 6-8 weeks of pregnancy and then plateau, but remain detectable throughout.

This hormone is the foundation for pregnancy detection in both home and clinical laboratory tests. Home pregnancy tests detect hCG in urine, while blood tests can find it as early as 7-9 days after fertilization. If you have no pregnancy (both males and females), normal hCG levels are nowhere near 2 IU/L.

On top of that, hCG does more than just maintain progesterone production. It helps build a thicker uterine lining to support fetal development and tells the body to stop menstruating. The hormone also stimulates the thyroid gland and helps the blastocyst implant.

Beyond normal pregnancy, some cancerous cells can produce hCG. Higher hCG levels in non-pregnant people might point to various cancers, especially gestational trophoblastic disease, germ cell tumors, or cancers of the liver, stomach, pancreas, lung, breast, or skin. Because of this link, doctors often use hCG tests to diagnose cancer, check how well treatment works, or look for cancer coming back.

The liver breaks down most of the hCG hormone, and about 20% leaves the body through urine. Urine tests usually detect the beta subunit that the kidney has broken down into a core fragment.

Medical professionals use these threshold values for hCG in pregnancy testing: negative (<5 IU/L), indeterminate (5-25 IU/L), and positive (>25 IU/L).

What is the structure and origin of hCG?

Human chorionic gonadotropin consists of two different subunits—alpha (α) and beta (β). These subunits link together through charge interactions rather than covalent bonds. The protein contains 237 amino acids and weighs about 36.7 kDa. The alpha subunit makes up 14.5 kDa of this weight, and the beta subunit accounts for 22.2 kDa.

The alpha subunit has 92-93 amino acids and looks similar to other glycoprotein hormones: luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH). This shared structure explains why these hormones work in similar ways. The beta subunit stands out because it has 145 amino acids that give hCG its unique biological functions.

The genetic makeup shows that a single gene (CGA) on chromosome 6q21.1-23 codes for the alpha subunit. The beta subunit’s genetics are more intricate, with six non-allelic genes (CGB1, 2, 3, 5, 7, and 8) grouped on chromosome 19q13.3. These genes came from copies of the luteinizing hormone beta (LHB) gene, which explains their 85-99% DNA match.

HCG differs from LH because it has an extra C-terminal peptide (CTP) in its beta subunit. This 24-amino acid extension sits at positions 121-145, and LH doesn’t have it. This structural difference substantially affects how long the hormone stays active—hCG lasts about 37 hours in the bloodstream, much longer than LH’s 25-30 minutes.

Sugar molecules make up about 30% of hCG’s weight. The molecule has eight carbohydrate chains in total. Two N-linked oligosaccharides attach to the alpha subunit at Asn52 and Asn78. The beta subunit carries two N-linked glycans at Asn13 and Asn30, plus four O-linked glycans on serine residues at positions 121, 127, 132, and 138. These sugar attachments, especially sialic acid, affect how the hormone binds to receptors, functions biologically, and gets cleared from the body.

Specialized cells called syncytiotrophoblasts, which form the blastocyst’s outer layer, produce most of the hCG. These cells later become a key part of the placenta. The syncytiotrophoblast starts making hCG right after the fertilized egg implants in the uterine wall, making it the first pregnancy hormone from the developing placenta.

The body modifies hCG after it’s made, creating different forms: “regular” hCG from syncytiotrophoblasts, hyperglycosylated hCG (hCG-H) from cytotrophoblasts, and sulfated hCG (hCG-S) from the pituitary gland. Each form serves its own purpose during pregnancy. Regular hCG helps produce progesterone in the corpus luteum, while hyperglycosylated hCG works as a growth signal by triggering the transforming growth factor-β receptor (TGFβR) pathway.

The molecule’s structure features a small hydrophobic core with a surface area 2.8 times larger than a sphere, and most outer amino acids attract water. This design helps the hormone interact with its receptors and dissolve easily in the blood.

What are the different forms of hCG?

Human chorionic gonadotropin (hCG) includes four different molecular variants. Each variant has its own biological functions and comes from different cells. These variants exist because of differences in their glycosylation patterns and protein structure. They play diverse roles throughout pregnancy and in certain medical conditions.

Regular hCG

Regular hCG is the classic form of the hormone that villous syncytiotrophoblasts of the placenta produce. This variant works as an endocrine hormone. It helps produce progesterone in corpus luteal cells and supports cytotrophoblast growth. Regular hCG weighs 36.7 kDa and has two N-linked oligosaccharides on its alpha subunit. Its beta subunit contains two N-linked and four O-linked oligosaccharides. The hormone’s acidic nature (pI 3.5) gives it a longer half-life of about 37 hours. This is much longer than luteinizing hormone (LH), which lasts only 25-30 minutes.

Hyperglycosylated hCG

Hyperglycosylated hCG (hCG-H) is different from regular hCG because it has more complex carbohydrate side chains. It contains double-sized hexasaccharide O-linked sugars and larger triantennary N-linked structures. Sugars make up 39% of its weight, compared to 30% in regular hCG. Cytotrophoblast cells produce this form instead of syncytiotrophoblasts. HCG-H makes up 92% of total hCG in the third week after implantation and 73% in the fourth week. These levels drop faster after that.

HCG-H works differently from regular hCG. It acts as an autocrine factor similar to cytokines. Its main job is to help trophoblasts invade during implantation. This makes hCG-H levels a good early indicator of pregnancy success. Ongoing pregnancies show substantially higher concentrations than failed pregnancies.

Free beta-hCG

Free beta-hCG is the beta subunit that flows freely without binding to the alpha subunit. This form helps doctors monitor pregnancies and detect cancer. During prenatal screening, free beta-hCG levels help detect chromosomal problems like Down syndrome.

Many cancers produce high levels of free beta-hCG, including trophoblastic and non-trophoblastic tumors. Finding free beta-hCG in people who aren’t pregnant often means poor cancer outcomes. People who aren’t pregnant should have levels below 5 IU/L.

hCG beta-core fragment

The hCG beta-core fragment (βcf-hCG) is what’s left after the body breaks down hCG. It forms when the kidneys break down the beta subunit. This creates a small molecule that can’t perform biological functions.

Pregnant women and some cancer patients have this fragment in their urine. The amount of βcf-hCG compared to intact hCG changes during pregnancy. Early in pregnancy (weeks 2-6 after ovulation), βcf-hCG stays lower than intact hCG (median ratio 0.64). After weeks 5-6, βcf-hCG becomes the main form in urine (median ratio 2.84 for weeks 6-12).

Most store-bought pregnancy tests can find this fragment, but their sensitivity varies. Learning about how different hCG forms relate to each other gives vital information about pregnancy progress and possible complications.

How are hCG levels used in diagnosis?

Quantitative hCG measurement is the lifeblood of diagnosing pregnancy conditions and certain malignancies. Healthcare providers rely on this hormone’s detection in blood and urine to get a full picture of reproductive health issues.

Pregnancy confirmation

Blood or urine tests that detect human chorionic gonadotropin provide the quickest way to confirm pregnancy. Pregnant women’s blood and urine show hCG as early as 10 days after conception. Home pregnancy tests can detect hCG in urine, but blood tests offer greater sensitivity and provide accurate results within 7-10 days after conception.

Pregnancy confirmation typically starts with levels above 25 mIU/mL. Quantitative hCG measurements help determine the fetus’s exact gestational age. The hormone levels rise exponentially during the first trimester and double approximately every 24 hours through the first 8 weeks. This doubling pattern indicates pregnancy viability.

The hormone levels peak around 10 weeks of gestation after their original rapid increase. The levels then decrease until week 16 and remain stable until term. Healthcare providers monitor the rise in hCG levels to ensure normal pregnancy progression.

Ectopic pregnancy and miscarriage

Unusual patterns in hCG progression often signal pregnancy complications. Healthcare providers use serial quantitative hCG testing to diagnose ectopic pregnancy and miscarriage when ultrasound results remain unclear.

Viable intrauterine pregnancies with original hCG levels below 1,500 mIU/mL show a 99% chance of increasing by at least 49% over 48 hours. Higher original levels show slower increase rates—approximately 40% between 1,500-3,000 mIU/mL and 33% above 3,000 mIU/mL.

Nonviable pregnancies often show hCG levels that plateau before 8 weeks or fail to double. Ectopic pregnancies typically show a slower rise without the expected doubling. The specific patterns include:

• A rise of less than 35% in 2 days points to ectopic pregnancy with 80.2% accuracy
• A 21% decrease over 48 hours suggests a failed intrauterine pregnancy
• Smaller decreases raise concerns about ectopic pregnancy

The discriminatory zone ranges from 1,500 to 3,500 mIU/mL—this represents the hCG level where intrauterine pregnancy becomes visible on transvaginal ultrasound. Levels exceeding this threshold without a visible intrauterine pregnancy suggest early pregnancy loss or ectopic pregnancy.

Gestational trophoblastic disease

Gestational trophoblastic disease (GTD) includes a variety of pregnancy-related disorders marked by abnormal trophoblast growth. Medical professionals rely heavily on hCG testing to diagnose and monitor these conditions.

Complete hydatidiform mole cases show hCG levels above 100,000 mIU/mL in early pregnancy. This level alone doesn’t confirm a diagnosis since normal pregnancies reach similar peaks around 8-11 weeks. Complete molar pregnancies make up 57.34% of GTD cases.

The International Federation of Gynecology and Obstetrics (FIGO) criteria diagnose post-molar gestational trophoblastic neoplasia through:

• hCG levels that stay within ±10% across four measurements over three weeks
• Levels increasing >10% across three values over two weeks
• Detectable serum hCG lasting longer than six months after molar evacuation

About 15-20% of patients develop gestational trophoblastic neoplasia after complete hydatidiform mole evacuation. Doctors monitor serial quantitative serum hCG every 1-2 weeks while levels remain elevated. Increasing or plateauing hCG levels diagnose invasive disease in cases of invasive mole or choriocarcinoma.

What are the medical and non-medical uses of hCG?

The clinical applications of human chorionic gonadotropin go beyond pregnancy detection and cover therapeutic uses in reproductive medicine, oncology, and unauthorized applications in sports.

Fertility and hormone therapy

Human chorionic gonadotropin is the lifeblood of fertility treatments for both sexes. Women receive hCG injections to trigger ovulation during assisted reproductive procedures. These injections mimic the natural luteinizing hormone surge. HCG helps final egg maturation and release from the ovary. This usually happens 36 hours after injection, which lets doctors time intrauterine insemination or egg retrieval in in vitro fertilization perfectly. The hormone also supports corpus luteum development after ovulation. This improves progesterone production, which is vital for embryo implantation.

Men with specific reproductive disorders benefit from hCG treatment. The FDA has approved hCG to treat hypogonadism. The hormone stimulates Leydig cells to produce testosterone and improve sperm production. This treatment works especially well for men who want to maintain fertility while treating testosterone deficiency. Traditional testosterone replacement therapy often reduces sperm production. HCG also helps treat cryptorchidism (undescended testicles) in prepubertal boys. Doctors use this treatment less often now because of potential side effects.

Tumor marker in cancer

Doctors have used serum hCG testing over the last several years to review therapeutic response and monitor recurrence or metastasis in specific malignancies. This biomarker helps manage gestational trophoblastic diseases, testicular germ cell tumors, and ovarian germ cell tumors. Tumor cells in these cases release varying amounts of free subunits into circulation.

The FDA hasn’t approved any hCG assays specifically for cancer detection. Doctors use pregnancy assays off-label when they have enough specificity and sensitivity for oncological applications. Clinical practice guidelines recommend hCG monitoring 4-6 times yearly during the first two years after treating testicular cancer. Advanced-stage cases need more frequent testing, up to 12 tests yearly.

hCG in sports and bodybuilding

Athletes who use anabolic-androgenic steroids often turn to hCG as a supporting substance. The hormone’s power to stimulate natural testosterone production makes it valuable during post-cycle therapy. It helps restore normal hormone levels and prevents testicular shrinkage after steroid use.

Sports governing bodies have banned hCG because it triggers testosterone production in males. The International Olympic Committee banned it in 1987. The World Anti-Doping Agency added it to their prohibited list in 2005. They detect the hormone through urine sample testing. Bodybuilders use hCG to reduce steroid use side effects, including testicular shrinkage and reduced fertility.

What are the controversies and misconceptions about hCG?

Medical science recognizes legitimate uses for human chorionic gonadotropin, but several myths and misconceptions need a closer look.

hCG diet and weight loss claims

The hCG diet combines hormone injections or supplements with an extremely low 500-calorie daily intake. A doctor first suggested this approach back in the 1950s, claiming it would burn fat while keeping muscle intact. Clinical trials have clearly shown that hCG plays no role in weight loss. The FDA hasn’t approved hCG to manage weight and warns that very restrictive diets with hCG could be harmful rather than helpful. The American Society of Bariatric Physicians advises against using hCG to lose weight. People who lose weight on this protocol do so because they eat very few calories, not from any hormone effects.

Homeopathic hCG products

Many “homeopathic” hCG weight loss products on the market contain zero actual hormone. These drops, pellets, and sprays often claim they can reset metabolism or create dramatic weight loss. The FTC has sued several companies, with one case resulting in a $1 million settlement over these unproven products. No scientific literature, homeopathic pharmacopeia, or recognized Materia Medica supports hCG as a valid homeopathic treatment.

Tetanus vaccine conspiracy theory

A widespread myth claims tetanus vaccines contain hCG as a hidden sterilization agent. This false idea came from 1990s research that studied birth control vaccines combining hCG with tetanus toxoid. These experimental vaccines never made it to production or secret distribution. Research has completely disproven these claims. The positive hCG results in the tested vaccines happened because pregnancy test kits were used incorrectly on vaccine samples containing preservatives. Studies have confirmed that tetanus vaccines are free of hCG.

Key Takeaways

Understanding hCG’s multiple forms and diagnostic applications is crucial for healthcare professionals and patients navigating pregnancy, fertility treatments, and cancer monitoring.

• hCG is produced by placental cells after implantation and serves as the primary pregnancy hormone, doubling every 2-3 days in early pregnancy • Four distinct hCG forms exist: regular hCG maintains pregnancy, hyperglycosylated hCG promotes implantation, free beta-hCG aids cancer detection • Abnormal hCG patterns help diagnose ectopic pregnancy (slow rise) and miscarriage (plateauing levels before 8 weeks) • hCG serves legitimate medical uses in fertility treatments and cancer monitoring but lacks FDA approval for weight loss • Popular hCG diet claims are scientifically unfounded—weight loss results from extreme calorie restriction, not the hormone itself

These insights highlight hCG’s critical role in reproductive health while dispelling dangerous misconceptions about unproven weight loss applications.

FAQs

Q1. What level of hCG confirms pregnancy? A pregnancy is typically confirmed when hCG levels in the blood exceed 25 mIU/mL. However, home pregnancy tests can detect hCG in urine as early as 10 days after conception, while blood tests can identify the hormone with greater sensitivity within 7-10 days after conception.

Q2. How quickly do hCG levels rise in early pregnancy? In normal pregnancies, hCG levels rise exponentially during the first trimester. They typically double every 24 hours for the first 8 weeks, reaching their peak around 10 weeks of gestation. After this, levels decrease until approximately week 16, where they remain relatively constant until term.

Q3. What are the different forms of hCG? There are four main forms of hCG: regular hCG produced by syncytiotrophoblasts, hyperglycosylated hCG from cytotrophoblasts, free beta-hCG, and the hCG beta-core fragment. Each form has unique functions and is used in different diagnostic contexts.

Q4. How is hCG used in fertility treatments? In fertility treatments, hCG injections are used to trigger ovulation in women during assisted reproductive procedures. For men, hCG can be used to treat hypogonadism by stimulating testosterone production and enhancing sperm production, without suppressing natural fertility.

Q5. Is hCG effective for weight loss? Despite popular claims, hCG has not been proven effective for weight loss. The FDA has not approved hCG for weight management, and clinical trials have shown that any weight loss observed in hCG diets is due to extreme calorie restriction rather than hormonal effects. The use of hCG for weight loss is considered controversial and potentially harmful.